Overview

Safety Study of Melatonin in Stroke Patients

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the effect of Melatonin (in a dosage of 14mg daily) for a better clinical outcome in the period three days post stroke.

Phase:

Phase 4

Details

Lead Sponsor:

Wolfson Medical Center

Treatments:

Melatonin